Dry Eye Syndrome Treatment Market Business Overview 2017 to 2027 by Top Key Players -Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd
The global dry eye syndrome treatment market is estimated to be valued at nearly US$ 3,560 Mn by 2017 end, and is projected to reach about US$ 6,610 Mn by the end of 2027, registering a CAGR of 6.4% over the forecast period.
View full press release